# Fresenius Medical Care to acquire NxStage Medical for $2 billion

Fresenius Medical Care signed an agreement to acquire NxStage Medical, a U.S. medical technology company, for approximately $2.0 billion, to strengthen its home dialysis and critical care presence.

- Type: Acquisition
- Announced: 2017-08-07
- Where: United States
- Value: $2.00B
- Status: announced
- Products: dialysis products, home dialysis devices, critical care devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Fresenius Medical Care](https://endata.com/companies/2053.md) (acquirer)
- [NxStage Medical](https://endata.com/companies/26086.md) (target)

## Sources

- [sec.gov](https://www.sec.gov/Archives/edgar/data/1333170/000119312517249858/d436075dex992.htm), 2017-08-07: "The acquisition supports our 2020 strategic initiative of driving growth in the core business with innovation, better clinical outcomes through Care Coordination and improving the patient experience."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
